Financial Transparency for Australia
The new Medicines Australia Code of Conduct will increase transparency about the vital role of healthcare professionals in the development and use of new, innovative medicines.
Financial Transparency for New Zealand
The new Medicines New Zealand transparency guidelines will increase transparency about the vital role of healthcare professionals in the development and use of new, innovative medicines.
Novartis provides funding opportunities for the general purposes of supporting healthcare initiatives from scientific and charitable organisations that directly support patients, improve healthcare and enable ongoing education that are aligned to our Therapeutic Areas.
Novartis is community and we are proud to support Australian charities and groups through our annual Community Partnership Day.
Novartis is supporting patient groups. These groups play a vital role in educating and supporting patients and we remain mindful of their independent perspectives with regard to diseases and their related treatments.
Our aim is to prevent issues from occurring, drive personal accountability for behaviors, and generate learnings that can be applied across the organization.
Ethics, Risk and Compliance
We recognize society’s expectations of our industry and of Novartis, and that we must go beyond just doing what is legal in order to meet legitimate expectations of society.
Access to medicines
We believe access to medicines is where we can have the greatest impact. For all our new medicines, we systematically integrate access strategies to reach underserved patients no matter where they live.
We understand the link between the health of our planet and the health of our patients. Our ambition is to be a catalyst for positive change and a leader in environmental sustainability.
We apply our expertise and full organizational capability to address major, unresolved global health challenges.